跳至主要内容
临床试验/JPRN-UMIN000020031
JPRN-UMIN000020031已完成未知

Efficacy of the escalating dose of naftopidil for patients with benign prostatic enlargement complicated by overactive bladder - Efficacy of naftopidil for BPH/OAB patients

Department of Urology Nagoya University Graduate School of Medicine0 个研究点目标入组 150 人开始时间: 2015年12月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 80years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Patients were excluded if they received oral treatment with alpha1-blockers, anticholinergic agents, 5-alpha reductase inhibitor (5-ARI), antidepressants, anti-anxiety agents, or sex hormonal agents; had neurogenic bladder dysfunction, bladder calculi, or active urinary tract infection; and had severe cardiac disease, renal dysfunction (serum creatinine level > 2 mg/dL), and hepatic dysfunction (aspartate and alanine aminotransferase concentrations more than twice the normal values).

研究者

发起方
Department of Urology Nagoya University Graduate School of Medicine

相似试验